Skip to main content
. 2010 Jan 14;181(12):1329–1335. doi: 10.1164/rccm.200812-1902OC

TABLE 1.

PATIENT DATA FROM 63 PARTICIPANTS PROVIDING LUNG TISSUE

GOLD Stage 0 (Control) 1 (Mild) 2 (Moderate) 3–4 (Severe)
Origin of lung tissue Van Van Van 4 Van, 8 SL
Location of lung tissues examined 3 RUL 4 RUL 4 RUL 2 RUL
4 RLL 4 RLL 2 RLL 2 RLL
6 LUL 4 LUL 7 LUL 4 LUL
3 LLL 6 LLL 4 LLL 4 LLL
No. of cases 16 18 17 12
No. of airways and surrounding tissues examined 35 37 36 28
FEV1/FVC, mean ± SD 78.2 ± 4.1 65.5 ± 3.6 58.8 ± 6.2 46.0 ± 12.8
FEV1, mean ± SD 96.2 ± 8.5 92.1 ± 8.9 65.6 ± 6.7 27.7 ± 12.0
Pack-years, mean ± SD 36.8 ± 17.2 50.9 ± 19.5 50.7 ± 30.6 49.9 ± 14.4
Former smokers 6 5 (2 n/a) 2 8 (2 n/a)
Years stopped smoking, mean ± SD 15.0 ± 10.3 7.4 ± 5.8 4.0 ± 4.2 5.4 ± 4.7
Steroid treatment, no. of patients 2 (2 n/a) 1 (3 n/a) 0 7 (1 n/a)
Age, mean ± SD 64.7 ± 8.5 63.6 ± 10.4 60.8 ± 9.0 60.4 ± 7.8

Definition of abbreviations: GOLD = Global Initiative for Chronic Obstructive Lung Disease; LLL = left lower lobe; LUL = left upper lobe; n/a = data not available; RLL = right lower lobe; RUL = right upper lobe; SL = Barnes Jewish Hospital (St. Louis, MO); Van = St. Paul's Hospital (Vancouver, Canada).